PeraHealth, a Charlotte, NC based provider of predictive, real-time clinical surveillance solutions has raised $14 million in funding from Mainsail Partners, a growth equity firm. As the healthcare industry progresses toward value-based care, high costs surrounding chronic diseases and infections continue to escalate. For example, sepsis kills 258,000 people in the U.S. every year and costs the U.S. healthcare system nearly $24 billion annually, according to the Sepsis Alliance.
PeraHealth is lowering the costs associated with the most expensive illnesses, such as sepsis, by helping clinicians identify patients most in need of care sooner, for earlier intervention through the use of its digital health solutions and Rothman Index, a proprietary patient acuity model and scoring system.
By leveraging the Rothman Index, a validated patient acuity score, PeraHealth software solutions enable healthcare providers to identify at-risk patients sooner for earlier intervention. Leading hospitals and health systems utilize PeraHealth’s real-time, predictive analytics to improve quality and reduce costs. Clinical results include lowering mortality rates as much as 30 percent.
The digital health startup plans to utilize the funding primarily for product development and building the organization including:
– Expand PeraWatch, a telehealth and remote monitoring solution for hospital and health systems
– Expand PeraMobile, an app which tracks and identifies at-risk patients for clinicians on-the-go.
– Grow PeraHealth’s internal team, including additions to the company’s customer service and clinical adoption teams, and support ongoing research and development.
To date, PeraHealth solutions are in use by more than 80 leading hospitals and care providers and help determine when to discharge patients; prioritize patient bedside visits and nursing assignments; improve documentation accuracy and timeliness; optimize ICU bed use; and identify opportunities for palliative care consults. Customers include Yale New Haven Health System, Houston Methodist, Children’s Hospital of Philadelphia, Memorial Sloan Kettering Cancer Center, and Mission Health. PeraHealth products are integrated with all major EHR vendors, enabling care providers to monitor patients at the unit, hospital and system-level.
“We’ve made significant strides in helping improve outcomes and lower costs with our current customers, but we’ve only scratched the surface and know we can broaden our solutions to help more health systems save patients’ lives,” says Stephanie Alexander, CEO of PeraHealth. “This funding provides PeraHealth with the resources to continue to transform healthcare through the intelligent use of data and grow our product portfolio built on the success of the Rothman Index.”
